Advertisement.

NMRA Projected Dividend Yield

Neumora Therapeutics Inc ( NASDAQ : NMRA )

Neumora Therapeutics is a clinical-stage biopharmaceutical company. Co. has scaled its therapeutic pipeline, which consists of seven clinical and preclinical neuroscience programs that target mechanisms of action for a range of neuropsychiatric disorders and neurodegenerative diseases. Co.'s primary product candidate, navacaprant (NMRA-140), is a once-daily oral kappa opioid receptor antagonist that is being developed for the treatment of major depressive disorder (MDD). Co. is initiating a Phase 3 program for navacaprant monotherapy in patients with moderate to severe MDD.

20 YEAR PERFORMANCE RESULTS

NMRA Dividend History Detail
NMRA Dividend News
NMRA Competitors News

# of Shares: 0

Closing Price: 10.32

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000